Expert Insights into the Efficacy and Safety of Brexucabtagene Autoleucel CART19 Cell Therapy in Adults with Advanced Acute Lymphoblastic Leukemia - Episode 5
Progression-Free Survival, Overall Survival, and the Prognostic Significance of Negative Minimal Residual Disease